Magnus Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-979
Closed -$257K 413
2020
Q2
$257K Sell
979
-39
-4% -$10.4K 0.03% 438
2020
Q1
$231K Buy
1,018
+84
+9% +$22.9K 0.03% 395
2019
Q4
$282K Buy
934
+25
+3% +$6.88K 0.04% 329
2019
Q3
$218K Sell
909
-114
-11% -$31.2K 0.04% 411
2019
Q2
$289K Buy
1,023
+67
+7% +$18.3K 0.06% 272
2019
Q1
$274K Hold
956
0.06% 277
2018
Q4
$251K Buy
+956
New +$263K 0.07% 256

Other funds holding ELV

Magnus Financial Group's ELV Position: Q3 2020 in Review

Magnus Financial Group sold out of Elevance Health (ELV) in Q3 2020, closing a stake of 979 shares — an estimated $257K sold.

Magnus Financial Group first reported a position in ELV in Q4 2018 and held it in 7 quarters. The position peaked at $289K in Q2 2019. 1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • Magnus Financial Group reported no remaining Elevance Health position as of Q3 2020 after selling out during the quarter.
  • Magnus Financial Group sold 979 Elevance Health shares in Q3 2020, an estimated $257K.
  • Magnus Financial Group first reported a position in Elevance Health in Q4 2018 and held it in 7 quarters.
  • Magnus Financial Group's Elevance Health position peaked at $289K in Q2 2019.
  • 1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on Magnus Financial Group's 13F filing for Q3 2020, filed 5 Nov 2020.